Correlations of CT scan with high-sensitivity C-reactive protein and D-dimer in patients with coronavirus disease

Jin Zhu1, Cheng Chen2, Rongshu Shi3

  • 1Jin Zhu, Department of Intervention, Affiliated Hospital of Zunyi Medical University, Zunyi 563003, P.R. China.

Insights

Chest CT scans in COVID-19 patients show characteristic findings correlated with C-reactive protein (CRP) and D-dimer levels. Elevated CRP and D-dimer in severe cases indicate poor prognosis and potential for predictive value.

Area of Science:

  • Medical Imaging
  • Infectious Diseases
  • Biomarkers

Background:

  • Coronavirus disease 2019 (COVID-19) presents with diverse clinical manifestations.
  • Assessing disease severity and patient prognosis is crucial for effective management.

Purpose of the Study:

  • To investigate the correlation between chest computed tomography (CT) scan findings and levels of high-sensitivity C-reactive protein (hs-CRP) and D-dimer in COVID-19 patients.
  • To evaluate the potential predictive role of these markers in clinical treatment and prognosis.

Main Methods:

  • Patients with COVID-19 were categorized into mild/ordinary (Group-1) and critical/severe (Group-2) based on established protocols.
  • Chest CT scans, hs-CRP, and D-dimer levels were analyzed and compared between groups.
  • Statistical analyses, including t-tests, nonparametric tests, and binary logistic regression, were employed.

Main Results:

  • Chest CT scans revealed characteristic abnormalities in COVID-19 patients, particularly ground-glass shadows and consolidations in severe cases.
  • Group-2 (critical/severe) exhibited significantly higher hs-CRP and D-dimer levels compared to Group-1 (mild/ordinary).
  • Chest CT findings demonstrated a significant positive correlation with hs-CRP and D-dimer levels (P<0.05).

Conclusions:

  • Chest CT scan findings in COVID-19 are characteristic and correlate with hs-CRP and D-dimer levels.
  • Elevated D-dimer and CRP levels are associated with severe and critical illness and are closely linked to patient prognosis.
  • These biomarkers may serve as valuable indicators for clinical treatment and prognosis evaluation in COVID-19 management.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
253
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
118
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
166
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
398
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
172
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
642